Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
117.25
+1.45 (1.25%)
At close: Oct 4, 2026
EGX:PHAR Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, EGX:PHAR stock has a consensus rating of "Hold" and an average price target of E£108.20. The average 1-year stock price forecast is 7.72% lower than the current stock price, while the lowest is E£100.00 (-14.71%) and the highest is E£116.40 (-0.72%).
Price Target: E£108.20 (-7.72%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for EGX:PHAR stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
10.67B
from 9.44B
Increased by 13.02%
Revenue Next Year
12.45B
from 10.67B
Increased by 16.71%
EPS This Year
6.44
from 8.89
Decreased by -27.56%
EPS Next Year
9.78
from 6.44
Increased by 51.86%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EGP.